Inactivation of lymphadenopathy associated virus by chemical disinfectants
Spire, B.; Barré-Sinoussi, F.; Montagnier, L.; Chermann, J.C.
Lancet 2(8408): 899-901
1984
ISSN/ISBN: 0140-6736 PMID: 6207400 DOI: 10.1016/s0140-6736(84)90657-3Document Number: 419790
Reverse transcriptase activity of lymphadenopathy associated virus was assayed after exposure to various standard chemical disinfectants. Ethanol [25%] or 1% glutaraldehyde should prove sufficient to disinfect medical instruments, and 0.2% sodium hypochlorite for cleaning floors and benches. Formalin 0.1% is too slow to be recommended.
Document emailed within 0-6 h
Related Documents
Larghi, O.P.; Savy, V.L.; Nebel, A.E. 1975: Inactivation of rabies virus by chemical agents Revista de la Asociacion Argentina de Microbiologia 7(3): 86-90Schmidt, B. 1974: Guide lines for the testing of chemical disinfectants Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 45(8): 378-388
Bergan, T.; Lystad, A. 1972: Practical use of chemical disinfectants in health institutions Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(28): 1847-1852
&na, &na; ,, 1987: Immunization of Children Infected with Human T-Lymphotropic Virus type Iii/Lymphadenopathy-Associated Virus The Pediatric Infectious Disease Journal 6(2): 209-211
1985: Leads from the MMWR. Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus JAMA 254(15): 2051-2052
1985: Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace Mmwr. Morbidity and Mortality Weekly Report 34(45): 681
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Ganaway, J.R. 1980: Effect of heat and selected chemical disinfectants upon infectivity of spores of Bacillus piliformis (Tyzzer's disease) Laboratory Animal Science 30(2 Pt 1): 192-196
Sitnikov, B.S.; Gendon, I.Z. 1970: "Rescue" of the rct40 plus-marker of vaccinia virus in different methods of inactivation of the donor virus Voprosy Virusologii 15(3): 278-283
Soule, H.; Luu Duc, D.; Mallaret, M.R.; Chanzy, B.; Charvier, A.; Gratacapcavallier, B.; Morand, P.; Seigneurin, J.M. 1998: Résistance des virus dans l'environnement hospitalier : le point sur l'activité virucide des désinfectants utilisés à l'état liquide - Virus survival in hospital environment : an overview of the virucide activity of disinfectants used in liquid form Annales de Biologie Clinique (Paris) 56(6): 693-703
Nicholson, J.K.; Cross, G.D.; Callaway, C.S.; McDougal, J.S. 1986: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) Journal of Immunology 137(1): 323-329
Khodorov, B.I. 1992: Slow inactivation and blockade of sodium channels of excitable membranes by chemical compounds Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 24-30
Ramsey, R.B.; Palmer, E.L.; McDougal, J.S.; Kalyanaraman, V.S.; Jackson, D.W.; Chorba, T.L.; Holman, R.C.; Evatt, B.L. 1984: Antibody to lymphadenopathy-associated virus in haemophiliacs with and without AIDS Lancet 2(8399): 397-398
Mentel', R.; Shirrmakher, R.; Kevich, A.; Dreĭzin, R.S.; Shmidt, I. 1977: Virus inactivation by hydrogen peroxide Voprosy Virusologii 6: 731-733
Becker, M.L.; Spracklen, F.H.; Becker, W.B. 1985: Isolation of a lymphadenopathy-associated virus from a patient with the acquired immune deficiency syndrome South African Medical Journal 68(3): 144-147
Botzenhart, K.; Herbold, K. 1988: Inactivation of hepatitis a virus in water by ozone Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 34(9): 508-510
Efimova, V.F.; El'bert, L.B.; Krutianskaia, G.L.; Kost, A.A.; Budovskiĭ, E.I. 1982: UV inactivation of the tick-borne encephalitis virus Voprosy Virusologii 1: 94-98